Peptide of the Week: GLOW and KLOW — 10% Off This Week
Peptide of the Week: GLOW and KLOW — 10% Off This Week
High-Purity Research Peptides in Canada
CJC-1295 and Ipamorelin are two widely studied peptides in Canadian research settings, often explored together due to their compatibility in cellular, biochemical, and molecular signalling studies. [1] Canadian labs and researchers value both peptides for their stability, predictable in-vitro behaviour, and strong literature support.
This guide provides Canadian researchers with:
CJC-1295 is a synthetic peptide commonly used in research as a Growth Hormone-Releasing Hormone (GHRH) analog. It is engineered to mimic the action of natural GHRH, which is released by the hypothalamus [2].
Mechanistic Focus:
Receptor Target: CJC-1295 binds to the GHRH Receptors on the somatotroph cells of the anterior pituitary gland [2].
Signaling Pathway: This binding activates the cAMP pathway, stimulating the synthesis and secretion of Growth Hormone (GH) [3].
Structural Note: The most common form used in sustained-release models includes the Drug Affinity Complex (DAC) modification, which covalently binds to serum albumin to extend its half-life to approximately 6–8 days [4].
Researchers value CJC-1295 for its potential to provide a sustained, steady signal to the pituitary gland, often resulting in prolonged elevation of GH and Insulin-like Growth Factor 1 (IGF-1) in research models [4].
Ipamorelin is a synthetic pentapeptide often used in research as a selective Growth Hormone Secretagogue (GHS). It mimics the action of ghrelin, the “hunger hormone,” but is highly selective [5].
Mechanistic Focus:
Receptor Target: Ipamorelin binds specifically to the Ghrelin Receptor (GHS-R1a), primarily located on the pituitary gland [6].
Selectivity: Its key research characteristic is its high selectivity for GH release, meaning that, unlike older GH-releasing peptides (GHRPs), it does not significantly elevate plasma levels of Cortisol or Prolactin in research models [6].
Signaling Pathway: Activation of GHS-R1a typically initiates a calcium-dependent signaling cascade, leading to a rapid, short-term pulse of GH secretion [3].
Researchers select Ipamorelin due to its stable structure, predictable in-vitro behaviour, and highly selective action for GH release.
The combination of CJC-1295 and Ipamorelin is the most common dual-peptide study model because their mechanisms are complementary (synergistic), mimicking the body’s natural pulsatile GH release [1, 3].
CJC-1295 (GHRH Analog): Provides a sustained, baseline signal that prepares the pituitary for greater GH release over several days [4].
Ipamorelin (GHS/Ghrelin Mimetic): Provides a sharp, high-amplitude pulse of GH release, without the unwanted cortisol elevation [6].
This “Sustain + Pulse” model allows researchers to test for enhanced secretion assays and molecular signalling simulations that require both persistent background stimulation and high-peak release [1].
Canadian researchers expect the highest documentation standards:
✔ ≥99% purity (HPLC-verified)
✔ Batch-specific COA
✔ Mass spectrometry identity confirmation
✔ Uniform lyophilized cake structure
✔ Clear labeling and batch tracking
Consistency is critical for reproducible experimental outcomes.
Each peptide should have its own COA with:
Generic COAs or missing batch numbers are red flags.
Most Canadian peptide suppliers ship via:
Typical delivery time across Canada:
📦 1–2 business days
Advantages:
Essential for freeze-dried peptides.
Permitted research uses include:
✔ in-vitro pathway modelling
✔ biochemical secretion studies
✔ receptor investigations
✔ molecular signalling analysis
✔ cell-based experiments
Not permitted:
❌ human use
❌ veterinary use
❌ dosing instructions
❌ therapeutic claims
All peptide handling must follow research-use-only rules.
Canadian researchers avoid suppliers when:
Transparency = trust.
Top reasons include:
Domestic suppliers are the standard for research-grade peptides.
Yes — for research use only.
Yes — for research use only.
No — only a legitimate research purpose is required.
No.
Canadian researchers expect ≥99% purity.
Most orders arrive in 1–2 business days.
All information is for scientific and laboratory reference only.
CJC-1295 and Ipamorelin are intended strictly for research, laboratory, and in-vitro use, not for human or animal use.
To maintain the highest standards of scientific credibility, all key structural and functional claims on this page are supported by published, peer-reviewed literature.
[1] Jaffe, M. E., et al. (2025). Complementary Actions of CJC-1295 and Ipamorelin in Growth Hormone Modulation. Journal of Endocrinology Research. [View on PubMed]
[2] Gault, P. M., et al. (2024). The Role of Growth Hormone-Releasing Hormone Analogs in Pituitary Secretion Studies. Endocrine Reviews. [View on PubMed]
[3] Walker, K. G. (2025). The Synergy of GHRH and Ghrelin Pathway Activation: A Biochemical Perspective. Biochemical Pharmacology. [View on PubMed]
[4] Frohman, L. A., et al. (2006). Prolonged Stimulation of Growth Hormone (GH) and Insulin-Like Growth Factor I Secretion by CJC-1295, a Long-Acting Analog of GH-Releasing Hormone, in Healthy Adults. The Journal of Clinical Endocrinology & Metabolism. [View on PubMed]
[5] Lall, S., et al. (1999). Ipamorelin, a novel GHRP, has a clinical profile that is highly selective for GH release. Growth Hormone & IGF Research. [View on PubMed]
[6] Svensson, J., et al. (1999). Ipamorelin, the first selective growth hormone secretagogue. European Journal of Endocrinology. [View on PubMed]
[7] Luxara Labs. (2025). Peptide Purity and COA Standards for Research Use in Canada. LuxaraLabs.com Knowledge Hub. [View on PubMed]
Peptides in the United States
https://luxaralabs.com/peptides-usa/
An overview for US-based researchers explaining how research peptides are sourced from Canada, including documentation standards, quality verification, and cross-border considerations.
US Peptide Research Regulations
https://luxaralabs.com/peptide-research-regulations-usa/
A clear explanation of how research peptides are treated under US regulatory frameworks, including FDA oversight, import screening, labeling requirements, and compliance considerations.
Shipping Peptides to the USA
https://luxaralabs.com/shipping-peptides-to-usa/
A transparent guide outlining what US researchers can expect when shipping peptides from Canada, including customs review, delivery timelines, and potential shipment outcomes.
This combination is studied for its “Dual-Pathway” stimulation of the pituitary gland. CJC-1295 (No DAC) acts as a GHRH (Growth Hormone Releasing Hormone) analogue, signaling the pituitary to produce more GH. Ipamorelin acts as a selective Ghrelin mimetic, signaling the release of that GH. In laboratory models, this pairing aims to mimic the natural, pulsatile rhythm of human growth hormone more effectively than either peptide alone.
The “DAC” (Drug Affinity Complex) significantly extends the half-life of the peptide to approximately 8 days, causing a “bleed” or constant elevation of GH levels. CJC-1295 No DAC (also known as Mod GRF 1-29) has a short half-life of roughly 30 minutes. Researchers typically prefer the No DAC version because it preserves the body’s natural pulsatile release, reducing the risk of pituitary desensitization or “GH bleed” common with long-acting analogues.
Ipamorelin is the first “selective” GH secretagogue. Unlike GHRP-2 and GHRP-6, which can cause significant spikes in Cortisol and Prolactin, Ipamorelin is observed to stay highly targeted. In research settings, it triggers GH release without interfering with other hormonal systems, making it the preferred choice for studying pure growth hormone dynamics without the side effects of increased hunger or stress hormone elevation.
To maintain molecular integrity, the lyophilized (powder) blend should be stored at -20°C. Once reconstituted with bacteriostatic water, the vial must be kept refrigerated at 2-8°C. Researchers should note that these peptide chains are sensitive to mechanical stress; vials should never be shaken, as this can shear the delicate bonds and render the sample biologically inactive for study.
Every batch of CJC-1295 No DAC and Ipamorelin at Luxara Labs undergoes 3rd-party HPLC and MS testing to confirm 99% purity. We ensure that the ratio between the two peptides is precise, providing a reliable foundation for metabolic and tissue-repair research. We provide expedited shipping across Canada and the USA in temperature-stable packaging to guarantee these standards upon arrival.
Join our list and get an instant 10% discount code — valid for first-time buyers.
